Mb2296 is an uncharacterized protein from Mycobacterium bovis with 109 amino acids (full length). Its amino acid sequence is: MNRHSTAASDRGLQAERTTLAWTRTAFALLVNGVLLTLKDTQGADGPAGLIPAGLAGAAASCCYVIALQRQRALSHRPLPARITPRGQVHILATAVLVLMVVTAFAQLL . The protein has a UniProt ID of P64972 and is also known by the synonym BQ2027_MB2296 . Structural analysis suggests the presence of hydrophobic regions that may indicate membrane association, particularly in the C-terminal portion of the sequence.
The recombinant form of Mb2296 typically contains affinity tags (most commonly His-tag) that facilitate purification and detection, which are absent in the native form . The recombinant protein expressed in E. coli systems also exhibits post-translational modifications different from those in Mycobacterium bovis. To distinguish between native and recombinant forms, researchers should employ:
Western blotting with tag-specific antibodies
Mass spectrometry to identify tag-specific peptides
Size-exclusion chromatography to detect size differences due to added tags
N-terminal sequencing to confirm the presence of fusion tags
The E. coli expression system is the most documented and validated system for Mb2296 production . The protein is typically expressed as a fusion with an N-terminal His-tag for purification purposes. The pET vector system utilizing T7 promoters has been shown to be particularly effective for mycobacterial proteins, with potential protein yields reaching up to 50% of total cellular protein under optimized conditions .
For higher expression levels, researchers should consider:
BL21-Gold (DE3) E. coli strain, which has shown better enrichment factors compared to XL-1 strains in similar proteins
T7 promoter-based expression vectors (pET series) with IPTG induction
Temperature optimization (typically 18°C for overnight expression to enhance solubility)
Advanced optimization of Mb2296 expression can be achieved through N-terminal sequence modifications. Research has demonstrated that adding specific amino acid sequences to the N-terminus can significantly enhance protein yield.
The MSKIK N-terminal sequence has been documented to improve expression of recombinant proteins, likely by preventing or releasing ribosomal stalling . For Mb2296 specifically, implementing a FACS-based screening approach with a GFP reporter fusion can identify optimal N-terminal sequences that increase yield up to 30-fold in some protein constructs .
Methodology for N-terminal optimization:
Create randomized N-terminal sequence libraries fused to Mb2296
Include a C-terminal GFP reporter for fluorescence detection
Transform into expression hosts (preferably BL21-Gold DE3)
Perform FACS sorting to isolate high-expressing clones
Codon optimization can significantly impact Mb2296 expression levels. In studies with similar recombinant proteins, codon optimization alone has increased yield over 4-fold, and when combined with N-terminal sequence manipulation, yields increased up to 30-fold .
For Mb2296, consider these methodological approaches:
Analyze the native sequence for rare codons in E. coli using tools like the GenScript codon optimization tool
Optimize the 5' mRNA structure to minimize secondary structures that could impede translation initiation
Pay particular attention to the initial codons after the start codon, as these significantly impact expression levels
Consider using the TISIGNER bioinformatics tool to design optimal initial codons while maintaining the amino acid sequence
Implement the optimized sequence in experimental validation using comparative expression analysis
The His-tagged Mb2296 can be purified using immobilized metal affinity chromatography (IMAC) with the following optimized protocol:
Harvest cells after expression (typically after 16-18 hours at 18°C)
Lyse cells in a suitable buffer (typically Tris-based, pH 8.0)
Clarify lysate by centrifugation at 20,000 × g for 30 minutes
Apply supernatant to Ni-NTA resin pre-equilibrated with lysis buffer
Wash extensively with buffer containing 20-40 mM imidazole
Elute purified protein with buffer containing 250-300 mM imidazole
Dialyze against storage buffer (Tris/PBS-based buffer, pH 8.0 with 6% trehalose)
The purity of Mb2296 obtained through this method typically exceeds 90% as determined by SDS-PAGE analysis .
Advanced researchers frequently encounter solubility challenges with membrane-associated proteins like Mb2296. To address these issues, implement the following methodological approaches:
Expression temperature optimization: Lower the expression temperature to 18°C to enhance proper folding
Co-expression with chaperones: Consider co-expressing with folding chaperones like GroEL/GroES
Solubility tags: Fusion with solubility-enhancing tags such as GST or MBP
Detergent screening: Systematic testing of detergents (CHAPS, DDM, Triton X-100) at varying concentrations
Buffer optimization: Screen various buffer compositions, including:
| Buffer Component | Range to Test | Optimal for Mb2296 |
|---|---|---|
| pH | 6.0-9.0 | 8.0 |
| NaCl | 100-500 mM | 300 mM |
| Glycerol | 5-20% | 10% |
| Reducing agents | 1-10 mM DTT/BME | 5 mM DTT |
| Stabilizing agents | Various | 6% Trehalose |
Limited proteolysis: Identify and remove aggregation-prone regions
For refolding of Mb2296 from inclusion bodies, a stepwise dialysis approach with gradually decreasing denaturant concentration has shown promising results in similar mycobacterial proteins.
For comprehensive characterization of Mb2296, researchers should employ multiple complementary techniques:
SDS-PAGE: Assess purity and apparent molecular weight (expected ~12 kDa plus tag size)
Western blotting: Confirm identity using anti-His antibodies or custom antibodies against Mb2296
Mass spectrometry: Determine precise molecular weight and verify sequence integrity
Circular dichroism (CD): Analyze secondary structure elements
Size-exclusion chromatography: Evaluate oligomeric state and homogeneity
Dynamic light scattering: Assess size distribution and potential aggregation
Thermal shift assays: Determine protein stability under various conditions
For membrane association studies, consider:
Liposome binding assays
Detergent partitioning experiments
Hydrophobic interaction chromatography
As Mb2296 remains uncharacterized, a systematic approach to functional investigation includes:
Bioinformatic analysis:
Sequence homology comparison with characterized proteins
Structural prediction using tools like AlphaFold2
Domain identification and motif recognition
Genomic context analysis to identify functional relationships
Experimental approaches:
Pull-down assays to identify interaction partners
Yeast two-hybrid screening for protein-protein interactions
Knockout/knockdown studies in Mycobacterium to observe phenotypic effects
Localization studies using fluorescent protein fusions or immunofluorescence
Functional complementation experiments
Advanced structural studies:
X-ray crystallography
Nuclear magnetic resonance (NMR) spectroscopy
Cryo-electron microscopy
Purified Mb2296 requires specific storage conditions to maintain stability and activity. Based on experimental data, the following protocol is recommended:
Short-term storage: Store working aliquots at 4°C for up to one week
Long-term storage: Store at -20°C or -80°C in small aliquots to avoid repeated freeze-thaw cycles
Lyophilization: For extended stability, lyophilization in the presence of stabilizers (e.g., trehalose) is effective
For reconstitution of lyophilized Mb2296:
Briefly centrifuge the vial before opening
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add 5-50% glycerol (final concentration) for long-term storage
To thoroughly characterize and enhance Mb2296 stability:
Perform differential scanning fluorimetry (DSF) to determine melting temperatures (Tm) under various conditions
Conduct accelerated stability studies at elevated temperatures (4°C, 25°C, 37°C, 42°C)
Monitor aggregation propensity using dynamic light scattering over time
Evaluate the effects of various excipients on stability:
| Excipient Class | Examples | Typical Concentration Range |
|---|---|---|
| Sugars | Trehalose, sucrose | 5-10% |
| Polyols | Glycerol, sorbitol | 5-20% |
| Amino acids | Arginine, glycine | 50-100 mM |
| Surfactants | Polysorbate 80, 20 | 0.01-0.1% |
| Salts | NaCl, (NH₄)₂SO₄ | 100-500 mM |
Implement protein engineering approaches such as:
Surface charge optimization
Disulfide bond introduction
Glycosylation site addition (for eukaryotic expression systems)
Stabilizing mutation identification through computational design
When facing low expression yields, implement this systematic troubleshooting approach:
Optimize expression conditions:
Enhance expression constructs:
Implement advanced molecular techniques:
To manage inclusion body formation during Mb2296 expression:
Prevention strategies:
Recovery strategies:
Optimize inclusion body isolation through differential centrifugation
Implement a refolding protocol:
| Step | Procedure | Parameters |
|---|---|---|
| Solubilization | Denature in 8M urea or 6M guanidine HCl | pH 8.0, 5 mM DTT |
| Purification | IMAC under denaturing conditions | Linear imidazole gradient |
| Refolding | Dialysis or dilution | Gradual denaturant removal |
| Polishing | Size exclusion chromatography | Remove aggregates |
On-column refolding:
Bind denatured protein to Ni-NTA under denaturing conditions
Gradually decrease denaturant concentration while protein remains bound
Elute refolded protein with imidazole
To systematically investigate Mb2296's biological function:
Gene knockout studies:
Create Mb2296 deletion mutants in M. bovis
Perform comparative phenotypic analyses (growth rates, morphology, virulence)
Conduct complementation studies to confirm phenotype specificity
Transcriptomic and proteomic analyses:
Compare wild-type and Mb2296 knockout strains
Identify genes/proteins with altered expression
Map potential regulatory networks
Localization studies:
Generate fluorescent protein fusions
Employ immunogold electron microscopy
Perform subcellular fractionation and Western blotting
Interaction partner identification:
Conduct pull-down assays with purified Mb2296-His
Perform bacterial two-hybrid screening
Use crosslinking mass spectrometry (XL-MS)
Structural biology approaches:
Determine crystal structure
Implement molecular dynamics simulations
Identify potential binding pockets or active sites
For evolutionary significance assessment, researchers should:
Perform comprehensive phylogenetic analysis:
Identify homologs across mycobacterial species
Construct phylogenetic trees to trace evolutionary relationships
Calculate selection pressures (dN/dS ratios)
Conduct comparative genomics:
Analyze gene neighborhood conservation
Identify syntenic regions across species
Examine co-evolution with functionally related genes
Implement structural comparative analysis:
Compare predicted structures with homologous proteins
Identify conserved structural elements
Map conservation onto three-dimensional structures
Functional conservation testing:
Express homologs from different species
Test functional complementation in knockout models
Compare biochemical properties across homologs
This evolutionary approach may reveal conserved functions that have been maintained through selective pressure, potentially indicating essential roles in mycobacterial physiology or pathogenesis.
To position Mb2296 research within systems biology:
Network integration approaches:
Map protein-protein interactions involving Mb2296
Identify metabolic pathways potentially affected by Mb2296
Construct regulatory networks incorporating Mb2296
Multi-omics data integration:
Combine transcriptomics, proteomics, and metabolomics data
Implement computational models to predict system-wide effects
Apply machine learning for pattern recognition across datasets
Functional genomics strategies:
Conduct high-throughput phenotypic screening of Mb2296 mutants
Implement CRISPRi for controlled gene repression
Analyze epistatic interactions with other genes
Mathematical modeling:
Develop kinetic models of pathways involving Mb2296
Simulate cellular responses under various conditions
Predict emergent behaviors at the system level
This integrative approach can reveal non-obvious relationships and contextual importance of Mb2296 within the complex biology of Mycobacterium bovis.